NCT00482313View on ClinicalTrials.gov

Efficacy and Effectiveness of Methylphenidate in Swedish Male Prison Inmates With Attention-deficit Hyperactivity Disorder (ADHD)

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

PR OROS Methylphenidate

PR OROS Methylphenidate given orally once daily for 5 weeks. The dosage was as follows: 36 mg per day from day 1-3, 54 mg per day from day 4-7 and 72 mg per day from day 8 until end of 5th week.

DRUG

Placebo

Sugar pill

Trial Locations (1)

141 86

Stockholm County Council, Psychiatry Southwest Karolinska, Huddinge

All Listed Sponsors
collaborator

Ministry of Health and Social Affairs, Sweden

OTHER_GOV

collaborator

Region Stockholm

OTHER_GOV

lead

Psychiatry Karolinska

OTHER

NCT00482313 - Efficacy and Effectiveness of Methylphenidate in Swedish Male Prison Inmates With Attention-deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter